NCT05743621
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
Clinical trial condition
Prostatic Neoplasms
Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.
36 public trials
14 recruiting studies
Prostatic Neoplasms trial results
NCT05944237
- Conditions
- Adenoma, Colonic Diseases, Colorectal Neoplasms, +61 more
- Locations
-
- Addenbrooke's Hospital Cambridge, United Kingdom
- Velindre Cancer Centre Cardiff, United Kingdom
- Clatterbridge Cancer Centre Liverpool, United Kingdom
- Guy's Hospital London, United Kingdom
NCT06276465
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
- Locations
-
- Groupe Hospitalier Bretagne Sud Lorient, France
- Centre Azuréen de Cancérologie Mougins, France
- CHU de Saint-Etienne Saint-Etienne, France
- Gustave Roussy Cancer Campus Villejuif, France
Recruiting
The Bispecific PSMAxCD3 Antibody CC-1 in Patients with Castration Resistant Prostate Carcinoma
NCT04104607
- Conditions
- Castration-Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +9 more
- Locations
-
- University Hospital Tuebingen Tübingen, Baden-Wurttemberg, Germany
- University hospital Heidelberg Heidelberg, BadenWuerttemberg, Germany
Not yet recruiting
Pluvicto Real-world Investigation in Survival in Metastatic CRPC
NCT07697989
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
- Locations
-
Not specified
Enrolling by invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +30 more
- Locations
-
- Linear Clinical Research Ltd Nedlands, Australia
- Scientia Clinical Research Randwick, Australia
- Ghent University Hospital Ghent, Belgium
- Hopital Claude Huriez Lille, France
Active, not recruiting
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT03431350
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Urological Associates of Southern Arizona, P.C. Tucson, Arizona, United States
- The Urology Center of Colorado Denver, Colorado, United States
- Mayo Clinic - Division Of Hematology/oncology Jacksonville, Florida, United States
- First Urology, PSC Jeffersonville, Indiana, United States
Active, not recruiting
A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer
NCT02592317
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
- Locations
-
- Chisinau, Moldova
- Barcelona, Spain
- Seville, Spain
Active, not recruiting
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
NCT03748641
- Conditions
- Castration-Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +9 more
- Locations
-
- Urology Centers Of Alabama Homewood, Alabama, United States
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Urological Associates of Southern Arizona, P.C. Tucson, Arizona, United States
- Arkansas Urology Little Rock, Arkansas, United States
Active, not recruiting
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT05057013
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +80 more
- Locations
-
- Royal Marsden NHS Foundation Trust London, United Kingdom
- The Christie Hospital Manchester, United Kingdom
- Freeman Hospital, Newcastle Newcastle, United Kingdom
- Churchill Hospital Oxford, United Kingdom